Kyle Simmons is a Production Coordinator at CCN. He focuses on themes related to medicine and healthcare, with a particular interest in medical specialties. Kyle's work has been featured in outlets such as The Journal of Clinical Psychiatry, Society19, and The Journal of Clinical Investigation.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Kyle Simmons primarily focuses on reviewing online casinos, with a significant emphasis on cryptocurrency and blockchain-related topics. Given this, he would likely be interested in expert insights related to the intersection of online gambling and cryptocurrency use.
Pitching industry experts or individuals with unique perspectives on the rise of cryptocurrency within the online gambling space could be particularly effective. Additionally, those who can provide valuable insight into specific casino platforms or trends within the industry may also capture Kyle's interest.
Since there is no specified geographic focus, pitches should cater to an international audience and consider global trends in online gambling and cryptocurrency usage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Who doesn't love and need life hacks? From study hacks to improve your grades, to kitchen hacks that will have you making convenient breakfasts and desserts, there are life hacks for everything.
By: Kyle Simmons, Sherry A. McKee, Manish K. Jha, Christian S. Hendershot, Louis A. Faillace
Affiliations & Notes a Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California
By: Kyle Simmons
Alcohol and other substance use disorders (SUDs) are chronic medical conditions associated with substantial medical, psychological, socioeconomic, and societal burden. The DSM-5 diagnosis of a SUD constitutes the presence of two or more of 11 symptoms over the past year, resulting in substantial clinical heterogeneity, with more than 2,000 symptom combinations possible. SUD includes three levels of severity: mild (2–3 symptoms), moderate (4–5 symptoms), and severe (6+ symptoms). The International Classification of Diseases system retains two diagnoses, harmful use (lower severity) and substance dependence (higher severity). Despite the availability of psychosocial, behavioral, and pharmacological treatments, SUDs remain leading causes of mortality and morbidity. FDA-approved medications exist for alcohol, opioid, and tobacco use disorders, but their numbers are few, and not all patients respond to these medications, underscoring the urgent need for developing additional effective medications.
